Currently, the treatment is given to stem cell transplant patients where no other treatment works.
That's what Mats Bemark, docent and developmental biologist at Sahlgrenska says.
According to him, the treatment should be able to reach more people within a few years.
- It will probably also be possible to treat organ transplant patients and people whose cancer was caused by a virus, says Mats Bemark, docent and developmental biologist at Sahlgrenska Hospital.
Hear him tell more about how virus-specific T-cell therapy could save more lives, in the video above.